- Home
- RELX vs GSK Comparison
RELX vs GSK Comparison
Compare RELX & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELX
- GSK
- Stock Information
- Founded
- RELX 1903
- GSK 1715
- Country
- RELX United Kingdom
- GSK United Kingdom
- Employees
- RELX N/A
- GSK N/A
- Industry
- RELX Business Services
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- RELX Consumer Discretionary
- GSK Health Care
- Exchange
- RELX Nasdaq
- GSK Nasdaq
- Market Cap
- RELX 84.6B
- GSK 81.9B
- IPO Year
- RELX N/A
- GSK N/A
- Fundamental
- Price
- RELX $45.83
- GSK $43.69
- Analyst Decision
- RELX Strong Buy
- GSK Hold
- Analyst Count
- RELX 2
- GSK 2
- Target Price
- RELX N/A
- GSK N/A
- AVG Volume (30 Days)
- RELX 1.3M
- GSK 5.7M
- Earning Date
- RELX 07-24-2025
- GSK 10-29-2025
- Dividend Yield
- RELX 1.91%
- GSK 3.72%
- EPS Growth
- RELX 3.29
- GSK N/A
- EPS
- RELX 1.42
- GSK 1.13
- Revenue
- RELX $13,062,063,298.00
- GSK $43,336,073,439.00
- Revenue This Year
- RELX $6.22
- GSK $5.43
- Revenue Next Year
- RELX $6.50
- GSK $5.14
- P/E Ratio
- RELX $32.08
- GSK $38.43
- Revenue Growth
- RELX 2.48
- GSK 0.59
- 52 Week Low
- RELX $44.19
- GSK $31.72
- 52 Week High
- RELX $56.33
- GSK $45.59
- Technical
- Relative Strength Index (RSI)
- RELX 41.10
- GSK 63.72
- Support Level
- RELX $45.22
- GSK $43.09
- Resistance Level
- RELX $46.78
- GSK $45.59
- Average True Range (ATR)
- RELX 0.43
- GSK 0.80
- MACD
- RELX 0.01
- GSK 0.23
- Stochastic Oscillator
- RELX 29.45
- GSK 73.17
About RELX RELX PLC PLC
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.